Khurana & Khurana, Advocates and IP Attorneys (K&K) is more than a full service Intellectual Property and Commercial Law firm. K&K was formed in the year 2007 with a very firm focus of providing end-to-end IP Prosecution/Litigation and Commercial Law services in a manner that is Corporate centric and follows stringent delivery practices that are consistent and are above defined quality standards. K&K works closely with its sister concern IIPRD, both of which supplement each other in order to provide end-to-end IP Legal and Commercialization/Licensing services to over 3000 Corporates. K&K is a team of over 65 professionals spread across 5 Offices in India, and has strong rankings from Legal 500, MIP, IAM, Chambers, Asia IP, among others.
Our team of IP Attorneys/Practitioners, having high level of technical and legal competence, gives us the right competitive edge and positioning, as a law firm focused on creating immense IP value for our clients. K&K through its experienced and qualified team of Attorneys/Practitioners, across Technology and Legal Domains, gives a rare synergy of legal opinion, out-of-box thinking for protection of ideas/IP's and entrepreneurial spirits to its client base. K&K earnestly believes that success comes only when one has a long-term perspective and this is why we concentrate on building long-term relationships through high level of client orientation.
K&K's critically focuses on a broad range of Technology Consulting and IP Research Services spanning all stages of IP Procurement, Management, and Enforcement. K&K has a diligent and earnest team of strong Patent, Commercial, and Legal Professionals who enable the firm to provide the complete spectrum of services starting from Market/Technology Research to Licensing/Commercialization to Litigation Support. K&K's over 8 years of substantive experience has helped it gain a prominent name in the Industry as a reliance and trustworthy partner in the complete Research and Analytics Process.
Khurana & Khurana, Advocates and IP Attorneys has been established precisely to help corporate leverage anticipated business and economic value from its efficient creation, protection and enforcement of their Intellectual Properties. Khurana & Khurana has created a unique and strategic position for itself by giving End-to-End IP services to its clients from the inception stage of creation of IP to successful commercialization of the IP for fulfillment of desired business objectives. The role and importance of patent professionals in IP (intellectual property) portfolio management (IPM) are increasing becoming significant within business, academic, and legal entities.View more
Khurana & Khurana has a legacy of over ten years in Patent Litigation and serves some of the leading Corporates for IP infringement matters. Our experience includes finding the potential infringers for the IP owners through due diligence and assessing the market for the same. For doing this, our firm has Patent/Trade Mark Attorneys/Practitioners who have advanced qualifications in varied technology domains and understand complete nuances of claim mapping and provisions of enforcement under different IP Laws.View more
Khurana & Khurana assists Corporates in maximizing opportunities from their IP portfolios through accurate legal opinions that ensure that all possible ways to solve a problem are identified and due-diligence of each way is put across in the right manner such that the client can take a judicious call on the way to proceed forward. K&K renders Prior art, Freedom to Operate, Validity, and Non-infringement opinions relating to a client’s products and technologies. K&K also prepares a comprehensive IP Litigation Strategy before initiating with a legal suit to ensure that the clients understands the next steps clearly, sets its expectations, and is cognizant of the costs involved in the process.View more
Commercial law governs the broad areas of business, commerce and consumer transactions. Commercial law in India has developed rapidly over the years with the opening up approach towards FDI and WTO. It allows, so far as it can, Corporate or person to do business in the way they want and not require them to stick to forms that they may think to be outmoded. Thus, Commercial Law Practice is recognized as a very important and integral element of any corporate operation, and is gaining more and more importance.In this era of globalisation, sweeping changes in business strategies require Corporates to meet challenge of complying with commercial contract law for the smooth functioning of its business and commerce.View more
The Internet Corporation for Assigned Names and Numbers (ICANN) is responsible for the administration of Top Level Domain Names. The Uniform Dispute Resolution Policy provides for the settlement of domain name disputes for the Generic Top Level Domains Name (GTLD) such as .com, .edu, .net, among others. The UDRP complaints may be filed with any of the ICANN accredited arbitration centres. UDRP also allows for the filing of the complaints at the jurisdictional civil court where the Registrant or the Registrar is located. Where the Registrar or the Registrant is located in India, the dispute may be resolved through legal action at the civil court.View more
Attorneys at Khurana & Khurana have developed significant experience in the area of anti-counterfeiting, especially in FMCG, Pharmaceuticals, Apparels, Footwear, and Medical Devices product verticals, and can assist in devising a comprehensive strategy for curbing counterfeit products by outlining all possible risks and assumptions and mapping them with costs involved in each step taken so that a judicious and objective step can be taken by the client..View more
The Biological Diversity Act of 2002 (BDA) is a piece of Indian legislation which came into being in response to compliance with the Convention on Biological Diversity (CBD), to which India is a ratified member. In fact, India has taken the lead among developing and developed nations both in introducing a substantive legislation in conformance … Continue reading Biological Diversity Act, 2002 and Patenting of Biological Inventions in India – Part I (Section – 6)
In the light of the recent order by Division Bench of Delhi High Court, this is an update to author’s prior blog dated April 5 2017 pertaining to the legal dispute between Nuziveedu Seeds and Mosanto. US-based agro major Monsanto Technology LLC and Hyderabad-based seed manufacturer Nuziveedu seeds had been locked in a long-term licensing … Continue reading Division Bench of Delhi HC stays restoration of Monsanto license agreements with Nuziveedu Seeds
With the emergence of globalization and sharp advancement of technologies, our society and its knowledge making has also changed steadily. The scope and range of knowledge has expanded and is only a click away, due to the expansion of digital connectivity. However with every pro come the cons. Infringements of copyrighted works are considered as … Continue reading Liability of online market portals vis-à-vis trademark infringement in the cyberspace
Technically YES. The Patents Act, 1970 (hereinafter referred to as the “Act”) is a piece of legislation, penalties under which are largely civil in nature, such as fines, award of monetary damages, injunction, loss of patentee rights including compulsory licensing, abandonment of application or revocation of a patent. However, violation of certain provisions, such as … Continue reading Can non-compliance of mandatory provisions under the patents act, 1970 land you behind the bars?
Publication of a patent application is one of the prime stages in the process of getting a patent. The publication date of the patent application is considered of a specific significance because the applicants’ advantages as well as rights start from the publication date. Even though the applicant cannot seek any infringement proceedings till the … Continue reading Early publication of patent application under the Indian patent law system
Reportedly, on an appeal filed by Cipla pertaining to COPD drug INDAFLO, the Delhi High court division bench maintained the interim injunction imposed by single judge against Cipla. As per the order, Cipla has now been restrained from, inter alia, using, manufacturing, importing, selling any pharmaceutical products etc. containing ‘INDACATEROL‘ or ‘INDACATEROL Maleate‘, alone or … Continue reading Injunction against Cipla COPD Drug ‘INDAFLO’ Upheld: Delhi High Court
Entertainment has had various developmental dimensions in each decade. From sitting under the sky and watching plays in person, to the same developing as a career. Then we evolved the idea of television, channelizing frequencies to look at people on a screen. Being black and white initially, we have seen added colours, LCD and LED … Continue reading Hidden Figures: Panasonics’s Invisible Television
Xtandi, the wonder drug for prostate cancer, was developed at UCLA, Los Angeles, by the innovation of NIH and Department of Defense grants. The drug was later licensed to Medivation, a biopharma company, which in October 2009 struck a deal with Japanese Astellas Pharma to collaborate on developing and commercializing Xtandi. The two companies now … Continue reading Delhi High Court sought Explanation through Counter Affidavit over Repudiation of Patent application for Xtandi
It has been a long time since M. Prabhakara Rao, the chairman of Nuziveedu Seeds, was trying to knock down the world’s largest seed company “Monsanto Co”, in a high-profile conflict over licensing and royalty of patented seed technology–Bollgard II. Finally, in a decision taken on 29th of March, M. Prabhakara Rao won the long-fought … Continue reading Nuziveedu seeds wins legal battle against US Giant Monsanto!
Texas-based Personalized Media communications, which is having a seminal intellectual property portfolio, has successfully signed a patent licensing agreement with Samsung Corporation and its affiliates. PMC patent portfolio includes around 100 issued patents and pending applications that cover the use of control and information signals to control automated systems for generating and delivering electronic content … Continue reading Samsung Patent Licensing Agreement with Personalized Media Communications
Qualcomm and the Chinese consumer electronics company Meizu recently announced that they had signed a licensing deal with each other. With this deal, they ended a yearlong infringement suit which was filed by Qualcomm against the Chinese company. In the October of 2016, we came to know that Qualcomm (the largest chipmaker in the world) … Continue reading Meizu – Qualcomm License Agreement Deal
BlackBerry once a phone innovator, was considered a game changer in 1999 when its mobile phone allowed on-the-go business people to access email wirelessly. BlackBerry devices were popular for a long time almost a decade. But with the introduction of the iPhone in 2007 and Google’s android in 2008 BlackBerry lost its market as a … Continue reading BlackBerry and India’s Optiemus Infracom sign’s licensing agreement to capture Asian smartphone market